Skip to main content
Clinical Trials/CTRI/2024/02/062980
CTRI/2024/02/062980
Recruiting
Phase 3

A randomized clinical trial evaluating the efficacy and safety of Jesners solution against 88% Phenol: In the treatment of Alopecia Areata. - Nil

Dr Rakesh Tilak raj0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: L638- Other alopecia areata
Sponsor
Dr Rakesh Tilak raj
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Rakesh Tilak raj

Eligibility Criteria

Inclusion Criteria

  • 1\.who has not received any treatment during previous 2 months before commencing of the study.
  • 2\.Patients with minimum of two patches; ranging in circumference between 3cm to 10 cm.
  • 3\.Patients with patchy patches of stable AA over the scalp
  • 4\.Patients willing to be part of the study after informed consent.

Exclusion Criteria

  • 1\.Patients treated with any other topical agent or immunosuppressive drugs.
  • 2\.Patients with scarring alopecia and scalp condition affecting the outcomes.
  • 3\.Patients who were on any allopathic or homeopathic treatment.
  • 4\.Patients with psychiatric medications and unrealistic expectations.
  • 5\.Pregnant and lactating mothers.
  • 6\.Patients with a history of keloid and hypertrophic scars.
  • 7\.Patient with any systemic disease (Cardiac, Renal, Hepatic, HIV, etc).
  • 8\.Patient with history of drug abuse.
  • 9\.Patient with collagen vascular disorder and auto\-immune.
  • 10\.Patients with alopecia totalis and universalis.

Outcomes

Primary Outcomes

Not specified

Similar Trials